LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
企業コードLMAT
会社名LeMaitre Vascular Inc
上場日Oct 19, 2006
最高経営責任者「CEO」Lemaitre (George W)
従業員数651
証券種類Ordinary Share
決算期末Oct 19
本社所在地63 2nd Ave
都市BURLINGTON
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号01803
電話番号17812212266
ウェブサイトhttps://www.lemaitre.com/
企業コードLMAT
上場日Oct 19, 2006
最高経営責任者「CEO」Lemaitre (George W)